Page last updated: 2024-08-25

methotrexate and Cryptogenic Fibrosing Alveolitis

methotrexate has been researched along with Cryptogenic Fibrosing Alveolitis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (72.73)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Li, S; Shi, J; Tang, H1
Xie, M; Ye, Y; Zhu, C1
Beijer, E; Grutters, JC; Meek, B; Roodenburg-Benschop, C; Schimmelpennink, MC; Veltkamp, M1
Affleck, A; Goudie, A; Smith, R3
Abdelmaksoud, A1
Gohar, A2
Fukui, S; Hishima, T; Kamei, S; Kobayashi, S; Setoguchi, K; Takizawa, Y1
Collard, HR; Elicker, BM; Kim, EJ; King, TE; Lee, JS; Maldonado, F; Ryu, JH; Van Uden, JH; Webb, WR1

Reviews

2 review(s) available for methotrexate and Cryptogenic Fibrosing Alveolitis

ArticleYear
Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.
    Cell biology and toxicology, 2022, Volume: 38, Issue:5

    Topics: Amiodarone; Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Lung; Lung Diseases, Interstitial; Methotrexate

2022
Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    BMC pulmonary medicine, 2023, Jul-11, Volume: 23, Issue:1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Idiopathic Pulmonary Fibrosis; Incidence; Lung Diseases, Interstitial; Male; Methotrexate; Prognosis; Risk Factors

2023

Other Studies

9 other study(ies) available for methotrexate and Cryptogenic Fibrosing Alveolitis

ArticleYear
Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype.
    Cells, 2021, 03-07, Volume: 10, Issue:3

    Topics: Adult; Aged; Alveolitis, Extrinsic Allergic; C-Reactive Protein; Case-Control Studies; Cohort Studies; Female; Gene Expression; Granulomatosis with Polyangiitis; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Sarcoidosis; Serum Amyloid A Protein

2021
Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Aged, 80 and over; Dermatologic Agents; Fatal Outcome; Humans; Idiopathic Pulmonary Fibrosis; Methotrexate; Psoriasis

2019
Comment on 'Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis'.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Humans; Idiopathic Pulmonary Fibrosis; Methotrexate; Psoriasis

2019
Lungs, methotrexate and psoriasis.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Humans; Idiopathic Pulmonary Fibrosis; Methotrexate; Psoriasis

2019
Comment on 'Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis': reply from author.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Methotrexate; Psoriasis

2019
Reply to Gohar on 'Lungs, methotrexate and psoriasis', a comment on 'Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis'.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Humans; Idiopathic Pulmonary Fibrosis; Lung; Methotrexate; Psoriasis

2019
Response to 'Reply to Gohar on "Lungs, methotrexate and psoriasis", a comment on "Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis"'.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:8

    Topics: Humans; Idiopathic Pulmonary Fibrosis; Lung; Methotrexate; Psoriasis

2019
Usual interstitial pneumonia following resolution of cavitated pulmonary masses in a patient with ANCA-associated vasculitis.
    International journal of rheumatic diseases, 2018, Volume: 21, Issue:4

    Topics: Aged; Cyclophosphamide; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Methotrexate; Microscopic Polyangiitis; Prednisolone; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2018
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.
    The European respiratory journal, 2010, Volume: 35, Issue:6

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Idiopathic Pulmonary Fibrosis; Kaplan-Meier Estimate; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Prognosis; Retrospective Studies; Tomography, X-Ray Computed

2010